CapMan’s operative performance in Q4 was quite decent with the big surprise being the divestment of ...
DT delivered solid Q4 growth. EBIT came down with high cost inflation.
Redeye updates its view on Evolution post Q4-results which came in just above our expectations and w...
Redeye states that the Q4 report was good, leading to a well-deserved relief to the share price.
Redeye provides a preview ahead of Fragbite Groups Q4 report, due on 23th February, where we slightl...
Redeye comments on Spago’s Q4 2022 report, and we estimate that the company is making solid progress...
FY'22 PTP guidance DKK ~600m, at high end of the old range Strong Q4e based on 21% NII growth q-o-q ...
We expect Q4 to be on the soft side The focus will be on the leadership changes.
Q4e: EBITDA of NOK 17.9m Margins set to rise in '23e on lower e-com investments '23e adj.
Redeye endorses that NeoDynamics partners with Uniphar for US distribution and logistics.
Stronger than expected sales but weak EBIT FDA's observations in the US being addressed Conference c...
DT’s Q4 and 22 EBIT saw an expected decrease. Group topline however grew nicely and soft Q4 profitab...
CapMan reported Q4 EBIT of 7.5m, 26% below Refinitiv consensus.
Redeye comments on Evolution’s Q4-results which came in slightly above our expectations.
Redeye comments Better Collective’s announcement that it has acquired a position of 5% in Catena Med...
Redeye states that Fram Skandinavien Q4 ’22 report was weaker than expected, but Carmudi beat our es...
Sales -3% vs. ABGSCe Adj. EBITDA -13% vs. ABGSCe Solid working capital management Q4 report The rep...
Hansa's Q4 is slightly below our and the market's sales expectations and slightly better in terms of...
Redeye comments on Sivers Q4'22 report which showed slightly better sales and EBITDA compared to our...
This morning, Vow announced that the company has received orders for three Safesteril food safety sy...
